Recent guidance in response to COVID-19:

​​

• FDA clinical trials guidance: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-public-health-emergency?utm_campaign=FDA%20Updates%20Question-and-Answer%20Appendix%20in%20Guidance&utm_medium=email&utm_source=Eloqua

​

• DPA guidance: https://iapp.org/resources/article/dpa-guidance-on-covid-19/

​

• EEOC guidance for ADA, Rehabilitation Act: https://www.eeoc.gov/wysk/what-you-should-know-about-ada-rehabilitation-act-and-coronavirus?renderforprint=1

​

• HHS guidance: https://www.hhs.gov/hipaa/for-professionals/special-topics/hipaa-covid19/index.html and https://www.hhs.gov/sites/default/files/hipaa-and-covid-19-limited-hipaa-waiver-bulletin-508.pdf

​

• FAQs on Telehealth and HIPAA: https://www.hhs.gov/sites/default/files/telehealth-faqs-508.pdf

​

• CMS partner toolkit: https://www.cms.gov/outreach-education/partner-resources/coronavirus-covid-19-partner-toolkit

​

​

​

​

​